FOXD3 and small cell lung carcinoma: When compared to normal controls (P < 0.0001), the expression of FOXD3-AS1 was significantly higher in lung tumors, regardless of whether they were LUAD, LUSC, or SCLC (Figures 2(c)–2(e)).